Abstract
A battery of screening systems are under development to validate compounds for further development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gura, T. Science 278, 1041–1042 ( 1997).
Waldman, T. et al. Nat. Med. 3, 1034–1036 ( 1997).
Lewis, R. Gen. Eng. News Oct. 1, 18 (1997).
Dutton, G. Gen. Eng. News Oct. 1, 17 (1997).
Glaser, V. Gen. Eng. News Sept. 15, 11 (1997 ).
Lerner, C.G. et al. Anal. Biochem. 240, 185–196 (1996).
Miura, M. & Yuan, J. Methods Enzymol. 322, 480 –492 (2000).
Hosler, G.A. et al. Leukemia 14, 1215–1224 (2000).
Boehm, H.J. et al. J. Med. Chem. 43, 2664–2674 (2000).
Rights and permissions
About this article
Cite this article
Lead validation platforms. Nat Biotechnol 18 (Suppl 10), IT47–IT49 (2000). https://doi.org/10.1038/80088
Issue Date:
DOI: https://doi.org/10.1038/80088
